» Articles » PMID: 35689780

Impact of Impaired Renal Function on Outcomes of Chronic Total Occlusion Undergoing Revascularization: a Systemic Review and Meta-analysis

Overview
Publisher Springer
Specialty Nephrology
Date 2022 Jun 11
PMID 35689780
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patients with chronic kidney disease (CKD) have an associated burden of coronary artery disease, including chronic total occlusions (CTO). It is unclear how the presence of CKD affects the outcomes of CTO revascularization. Previous reviews have not taken into account all relevant published studies that examined the association of CKD with outcomes of CTO revascularization.

Methods: A systematic search was conducted using PubMed, Scopus, and Google Scholar databases for studies investigating patients with or without CKD who also had coronary chronic total occlusion undergoing revascularization procedures Statistical analysis was performed using STATA software. Effect sizes were reported as pooled relative risk (RR).

Results: A total of 13 studies were included. CKD patients showed elevated risk of in-hospital mortality (RR 4.25, 95% CI 2.64, 6.82) and mortality at latest follow-up (RR 3.24, 95% CI 2.56, 4.11), elevated risk of major cardio or cerebrovascular events (RR 1.65, 95% CI 1.38, 1.98), major bleeding (RR 2.85, 95% CI 1.96, 4.13), and contrast-induced acute kidney injury (RR 3.06, 95% CI 1.70, 5.52). CKD patients also showed lower chances of technical success (RR 0.95, 95% CI 0.91, 1.00).

Conclusions: The presence of CKD increases the risk of mortality, complications and adversely affects the success of CTO revascularization. Patients with CKD undergoing revascularization should have their kidney function comprehensively evaluated and these patients should be carefully monitored.

Citing Articles

Impaired Kidney Function and 10-Year Outcome After Percutaneous Coronary Intervention-Interaction with Age, Sex, Diabetic Status and Clinical Presentation.

Ndrepepa G, Kufner S, Cassese S, Joner M, Sager H, Xhepa E J Clin Med. 2024; 13(22).

PMID: 39597977 PMC: 11594875. DOI: 10.3390/jcm13226833.


Association of chronic kidney disease with postoperative outcomes: a national surgical quality improvement program (NSQIP) multi-specialty surgical cohort analysis.

Riveros C, Ranganathan S, Shah Y, Huang E, Xu J, Hsu E BMC Nephrol. 2024; 25(1):305.

PMID: 39272061 PMC: 11401401. DOI: 10.1186/s12882-024-03753-1.

References
1.
Werner G, Gitt A, Zeymer U, Juenger C, Towae F, Wienbergen H . Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin Res Cardiol. 2009; 98(7):435-41. DOI: 10.1007/s00392-009-0013-5. View

2.
Irving J . CTO pathophysiology: how does this affect management?. Curr Cardiol Rev. 2014; 10(2):99-107. PMC: 4021289. DOI: 10.2174/1573403x10666140331142349. View

3.
Kearney K, Hira R, Riley R, Kalyanasundaram A, Lombardi W . Update on the Management of Chronic Total Occlusions in Coronary Artery Disease. Curr Atheroscler Rep. 2017; 19(4):19. DOI: 10.1007/s11883-017-0655-0. View

4.
Weintraub W, Garratt K . Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Not Routinely Be Treated With Coronary Artery Bypass Grafting. Circulation. 2016; 133(18):1818-25. PMC: 5505506. DOI: 10.1161/CIRCULATIONAHA.115.017798. View

5.
Ybarra L, Cantarelli M, Lemke V, Schaan de Quadros A . Percutaneous Coronary Intervention in Chronic Total Occlusion. Arq Bras Cardiol. 2018; 110(5):476-483. PMC: 5967142. DOI: 10.5935/abc.20180077. View